Specialty and rare diseases are characterized by undefined patient populations that are undiagnosed or misdiagnosed, healthcare providers unaware of disease states and treatment journeys that are not well-understood.

Enter IPM.ai

Through ML/AI, we transform real world data into real world insights across the product lifecycle to uncover the ideal patient and their healthcare ecosystem and accelerate the commercialization of lifesaving therapies.